EFFICACY OF LOW OR STANDARD DOSE RITUXIMAB AS COMPARED TO PONTICELLI'S REGIMEN IN MEMBRANOUS NEPHROPATHY

被引：0
|
作者：
Roccatello, Dario [1 ,2 ]
Fenoglio, Roberta [1 ,2 ]
Sciascia, Savino [1 ,2 ]
机构：
[1] S Giovanni Bosco Hosp, Turin, Italy
[2] Univ Turin, Turin, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP239
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy
    Roberta Fenoglio
    Simone Baldovino
    Savino Sciascia
    Emanuele De Simone
    Giulio Del Vecchio
    Michela Ferro
    Giacomo Quattrocchio
    Carla Naretto
    Dario Roccatello
    Journal of Nephrology, 2021, 34 : 565 - 571
  • [2] Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy
    Fenoglio, Roberta
    Baldovino, Simone
    Sciascia, Savino
    De Simone, Emanuele
    Del Vecchio, Giulio
    Ferro, Michela
    Quattrocchio, Giacomo
    Naretto, Carla
    Roccatello, Dario
    JOURNAL OF NEPHROLOGY, 2021, 34 (02) : 565 - 571
  • [3] A Study Comparing Rituximab and Modified Ponticelli (MP) Regimen in Primary Membranous Nephropathy(PMN)
    Kumar, Abhishek
    Chaudhury, Arpita Ray
    Gupta, Saugat D.
    Mukherjee, Sriranjan
    Sengupta, Moumita
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 513 - 513
  • [4] MODIFIED - 'MODIFIED PONTICELLI REGIMEN' - FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY
    Nagaraju, Shankar Prasad
    Parthasarathy, Rajeevalochana
    Prabhu, Ravindra Attur
    Kosuru, Srinivas
    Rangaswamy, Dharshan
    Mareddy, Aswani Srinivas
    Madken, Mohit
    Kaza, Sindhu
    Rao, Srikanth Prasad
    Laxminarayana, Sindhura Lakshmi Koulmane
    Guddattu, Vasudeva
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [5] Rituximab versus the modified Ponticelli regimen in the treatment of primary membranous nephropathy: a Health Economic Model
    Hamilton, Patrick
    Kanigicherla, Durga
    Venning, Michael
    Brenchley, Paul
    Meads, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (12) : 2145 - 2155
  • [6] Low-Dose Rituximab for Posttransplant Recurrent Membranous Nephropathy
    Cravedi, P.
    Ruggenenti, P.
    Remuzzi, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1336 - 1336
  • [7] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2090 - I2091
  • [8] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [9] STUDY OF HYPOTHALAMIC PITUITARY ADRENAL AXIS IN PATIENTS WITH MEMBRANOUS NEPHROPATHY RECEIVING MODIFIED PONTICELLI REGIMEN
    Kohli, Harbir
    Bhat, Ashok
    Bhansali, Anil
    Sud, Kamal
    Jha, V.
    Gupta, K. L.
    Sakhuja, Vinay
    NEPHROLOGY, 2005, 10 : A171 - A171
  • [10] EFFICACY OF RITUXIMAB IN A CASE OF PRIMARY MEMBRANOUS NEPHROPATHY
    Printza, Nikoleta
    Stabouli, Stella
    Dotis, John
    Georeli, Ireni
    Maliahova, Olga
    Sidira, Christina
    Papachristou, Fotios
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1777 - 1777
12345